drugset
drugset / Trial / NCT03007394

Lorcaserin in the Treatment of Cocaine Use Disorder

NCT03007394 ↗

Phase 2 Completed 272 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.

Timeline

Start
2017-12-19
Primary completion
2019-12-01
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lorcaserin Small molecule 10 mg Oral

Indications

substance-related disorder